Preclinical characterization of DEKAVIL (F8-IL10), a novel clinical-stage immunocytokine which inhibits the progression of collagen-induced arthritis
-
* Corresponding author: Dario Neri dario.neri@pharma.ethz.ch
Arthritis Research & Therapy 2009, 11:R142 doi:10.1186/ar2814
See related editorial by van de Loo and van den Berg, http://arthritis-research.com/content/11/6/132
Accesses
- Last 30 days: 92 accesses
- Last 365 days: 930 accesses
- All time: 3451 accesses